Hemlibra (Emicizumab) 30 mg/mL Injection
Hemlibra 30 mg/mL Injection is a prescription biologic medicine used mainly for the prevention and reduction of bleeding episodes in patients with hemophilia A. It contains Emicizumab, a recombinant monoclonal antibody that works by replacing the function of missing clotting factor VIII. Unlike traditional clotting factor therapies, it helps the blood clot more effectively and reduces spontaneous or repeated bleeding episodes.
This medicine is commonly used in patients with or without factor VIII inhibitors and is given as a long-term preventive therapy under medical supervision.
Contact Details to Place Order
💬 WhatsApp: +91 9730316395
📞 Phone: +91 9730316395
📧 Email: info@globmedindia.com
Composition and Content
- Active Ingredient: Emicizumab
- Strength: 30 mg/mL
- Dosage Form: Subcutaneous injection (pre-filled solution)
- Drug Class: Bispecific monoclonal antibody / Anti-hemorrhagic biologic
How It Works
Hemlibra works by:
- Mimicking the function of clotting factor VIII
- Bridging activated factor IX and factor X
- Helping the blood clot normally in hemophilia A patients
- Reducing spontaneous bleeding episodes
It provides continuous protection rather than treating bleeding only after it occurs.
Uses and Treatments
Hemlibra (Emicizumab) Injection is used for:
- Hemophilia A (congenital factor VIII deficiency)
- Hemophilia A with factor VIII inhibitors
- Hemophilia A without inhibitors
- Prevention of recurrent bleeding episodes
- Long-term prophylactic (preventive) treatment
Dosage and How to Use
- Administered as subcutaneous injection
- Initial loading dose followed by maintenance dosing
- Frequency may be weekly, biweekly, or monthly depending on prescription
- Should be administered by trained healthcare professionals or as instructed by a doctor
Important: Dosage is strictly individualized and must be followed under hematologist supervision.
Advantages of Hemlibra
- Reduces frequency of bleeding episodes
- Effective even in patients with factor VIII inhibitors
- Long-lasting preventive action
- Less frequent dosing compared to traditional therapies
- Improves quality of life in hemophilia patients
Storage Conditions
- Store in a refrigerator (2°C to 8°C)
- Do not freeze
- Keep in original carton to protect from light
- Do not shake vigorously
- Keep out of reach of children
Alternative Indian Brands / Biosimilar Options
Currently, Emicizumab is a patented biologic medicine, and direct Indian generic versions are not widely available. However, similar supportive hemophilia treatments in India include:
- Factor VIII concentrates by Shire (Takeda Pharmaceuticals) (available in India via authorized distribution)
- Plasma-derived clotting factor therapies by Indian plasma companies such as Reliance Life Sciences
- Recombinant factor products distributed by Bharat Serums and Vaccines
Note: Substitution must only be done under hematologist supervision.
Buy Hemlibra Emicizumab 30 mg/mL Injection Online in India – Trusted Biologic Medicine Exporter
Looking to buy Hemlibra Emicizumab 30 mg/mL Injection in India? GlobMedIndia is a trusted medicine exporter of biologic and anti-hemophilia treatments, offering genuine, safe, and quality-assured medicines with fast and secure delivery across India.
We specialize in supplying hemophilia A treatment injections with proper cold-chain handling and international pharmaceutical standards.
Why Choose GlobMedIndia?
- Trusted exporter of biologic medicines
- Proper cold-chain packaging and delivery
- Fast, safe, and secure shipping
- 100% genuine and quality-assured products
- Reliable global healthcare supply partner
- Buy Hemlibra Injection India
- Emicizumab 30 mg/mL price India
- Hemophilia A treatment injection India
- Hemlibra supplier India
- Anti bleeding injection India online
- Biologic medicine exporter India
- GlobMedIndia hematology medicines
👉 Order Now for Fast, Safe & Secure Delivery Across India!
